Carbazochrome sodium sulfonate

卡络磺钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCarbazochrome sodium sulfonate
Drug Alias Namecarbazocromo肾上腺色腙卡巴克洛carbazochromum肾上腺色素缩氨脲 +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryJapan
Original Approved Date1956/10/10
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeB02BX02